pr web

Mavenir Confirms Refocus Strategy on Mobile Core and AI Vision With Expanded Leadership Team to

EBC Financial Group Recognised as Best Broker for Execution at Professional Trader Awards 2025 Leave

Miltenyi Biomedicine presents primary analysis of the pivotal DALY 2-EU trial for second-line relapsed/refractory large